View Single Post
Old 03-01-2016, 10:30 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 20,142
Single dose of trastuzumab kick starts immune response in certain breast cancers

A tumor's immune response to a single dose of the HER2 inhibitor trastuzumab predicted which patients with HER2-positive breast cancer would respond to the drug on a more long-term basis, according...

More...
News is offline   Reply With Quote